Year 1

The 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases was organized to ensure that investigators and trainees in regenerative medicine and gene/cell-based therapy that do not have an opportunity to interact in other meetings are able to discuss and identify common areas of research interest, network, and form new collaborations. The intent is to advance current research approaches in the regenerative medicine field, and to overcome obstacles that limit new treatments from becoming a clinical reality for a host of diseases that impact the cardiovascular, pulmonary, and hematopoietic systems. The focus topic of the Symposium was Tolerance and Immune Modulation, a critical area of research and clinical investigation for stem cell transplantation and gene therapy.